06:41:50 EDT Tue 16 Apr 2024
Enter Symbol
or Name
USA
CA



Matica Enterprises Inc
Symbol MMJ
Shares Issued 315,791,822
Close 2021-04-15 C$ 0.045
Market Cap C$ 14,210,632
Recent Sedar Documents

Matica to miss 2020 results deadline, applies for MCTO

2021-04-15 17:54 ET - News Release

Mr. Boris Ziger reports

MATICA ANNOUNCES DELAYED FILING OF ANNUAL FILINGS

Matica Enterprises Inc., as a result of the COVID-19 pandemic measures, will not be in a position to file its audited annual financial statements, the related management's discussion and analysis, and related chief executive officer and chief financial officer certificates before the required deadline of April 30, 2021.

The company is working closely with its auditor and expects to file the annual filings on or before May 31, 2021. The company does not anticipate any delay in filing its interim financial statements, management's discussion and analysis, and the related officer certifications for the financial period ended March 31, 2021.

Matica has applied to the Ontario Securities Commission, as principal regulator for the company, for the imposition of a management cease trade order under National Policy 12-203 -- Management Cease Trade Orders (NP 12-203) over the duration of the default. If a management cease trade order is issued, it will generally not affect the ability of persons who have not been directors, officers or insiders of Matica to trade in their securities.

The company is providing this press release in accordance with National Policy 12-203 -- Management Cease Trade Orders (NP 12-203). The company intends to follow the provisions of the alternative information guidelines set out in NP 12-203, including the issuance of biweekly default status reports in the form of news releases, for as long as the company remains in default. The company confirms as of the date of this news release that there is no other material information concerning the affairs of the company that has not been generally disclosed.

About Matica Enterprises Inc.

Matica is a multifaceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc., is a Health Canada licence holder based in Dorval, Que. RoyalMax has been granted a standard cultivation licence, standard processing and medical sales licences by Health Canada.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.